Summary:
- This article discusses an executive order signed by former President Trump that aimed to improve the oversight and regulation of "gain-of-function" research, which involves modifying pathogens to study their potential to cause pandemics.
- The order required federal agencies to develop new policies and procedures for reviewing and approving this type of research, with the goal of enhancing biosafety and biosecurity measures.
- The article suggests that the order was a response to concerns about the potential risks of gain-of-function research, particularly in the context of the COVID-19 pandemic, and highlights the ongoing debate around the appropriate regulation and oversight of this type of scientific work.